<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03345771</url>
  </required_header>
  <id_info>
    <org_study_id>17-00496</org_study_id>
    <nct_id>NCT03345771</nct_id>
  </id_info>
  <brief_title>Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty</brief_title>
  <official_title>Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether an occlusive antimicrobial barrier dressing
      or portable negative pressure wound dressing is superior in preventing wound complications
      and infection rates in obese patients undergoing total joint arthroplasty (TJA).
      Approximately 240 subjects (120 for total knee arthroplasty and 120 for total hip
      arthroplasty) will be enrolled to evaluate the outcomes associated with silver impregnated
      dressings and negative pressure wound therapy (NPWT) in treating this subset of patients and
      analyze the cost benefit of each.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 13, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) pain score</measure>
    <time_frame>Day 8</time_frame>
    <description>0 = worst possible scar, 100 = best possible scar</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wound Evaluation Scale (WES)</measure>
    <time_frame>Day 8</time_frame>
    <description>Wound Evaluation Scale*
Stepoff borders (0 for yes, 1 for no)
Contour irregularity-puckering
Scar width-greater than 2 mm
Edge inversion-sinking, curling
Inflammation-redness, discharge
Overall cosmesis (0 = poor, 1 = acceptable) *6/6 = optimal wound healing.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Antimicrobial Barrier Dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>postoperative wound dressing with either anti-microbial dressing placed in the operating room from surgery to postoperative day 7</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Closed-incision Negative Pressure Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portable NPWT device placed in the operating room from surgery to postoperative day 7</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Antimicrobial Barrier Dressing</intervention_name>
    <description>Ionic Silver is a soft, nonwoven pad or ribbon that features the gelling benefits of Hydrofiber technology plus antimicrobial ionic silver.</description>
    <arm_group_label>Antimicrobial Barrier Dressing</arm_group_label>
    <other_name>AQUACEL Ag Hydrofiber Dressing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Negative Pressure Wound Therapy (NPWT)</intervention_name>
    <description>PICO provides suction known as negative Pressure wound Therapy (NPWT) which draws out excess fluid from a wound and protects the injured area from getting dirty to ultimately help promote healing. PICO consists of an nPwT pump connected to an absorbent gentle adhesive dressing</description>
    <arm_group_label>Closed-incision Negative Pressure Therapy</arm_group_label>
    <other_name>PICO</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Those identified at pre-operative testing to have an elevated BMI (&gt; 35)

        Exclusion Criteria:

          -  Active infection

          -  previous scar or wound healing complication

          -  post traumatic degenerative joint disease (DJD) with hardware

          -  revision surgery

          -  inflammatory arthritis

          -  anticoagulation outside of the standard of care.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Long, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Afshin Anoushiravani</last_name>
    <phone>212 598 6146</phone>
    <email>Afshin.Anoushiravani@nyumc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Afshin Anoushiravani</last_name>
      <phone>212-598-6146</phone>
      <email>Afshin.Anoushiravani@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>William Long, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>November 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>November 16, 2017</last_update_submitted>
  <last_update_submitted_qc>November 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

